I agree that this site is using cookies. You can find further informations here.
X
Lichtenstein, G R
1705  results:
Search for persons X
?
1

P790 Assessment of steroid use in patients with active ulce..:

Dubinsky, M C ; Gianfrancesco, M ; Gauthier, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1474-i1476 , 2024
Link: https://doi.org/10.1093/..
 
?
2

DOP52 Guselkumab improves symptoms of fatigue in patients w..:

Dignass, A ; Panés, J ; Rubin, D T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i166-i167 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P705 Assessment of age on the efficacy and safety among pat..:

Lichtenstein, G R ; Allegretti, J R ; Loftus Jr, E V...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1330-i1332 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P466 Efficacy and safety outcomes in patients with moderate..:

Mukherjee, R ; Khan, R M Q ; Liu, J J...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i594-i596 , 2023
Link: https://doi.org/10.1093/..
 
?
5

P607 Efficacy and safety of tofacitinib in Ulcerative Colit..:

Rubin, D T ; Vavricka, S R ; Armuzzi, A...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i538-i539 , 2022
Link: https://doi.org/10.1093/..
 
?
6

P539 Assessment of age as a risk factor for adverse events ..:

Lichtenstein, G R ; Bressler, B ; Vermeire, S...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S460-S461 , 2020
Link: https://doi.org/10.1093/..
 
?
7

DOP61 Tofacitinib, an oral, small-molecule Janus kinase inh..:

Lichtenstein, G R ; Loftus Jr, E V ; Wei, S C...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S100-S101 , 2020
Link: https://doi.org/10.1093/..
 
?
8

P479 Analysis of haematological changes in tofacitinib-trea..:

Lichtenstein, G R ; Moore, G T ; Soonasra, A...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S351-S352 , 2019
Link: https://doi.org/10.1093/..
 
?
9

DOP025 Tofacitinib for the treatment of ulcerative colitis:..:

Lichtenstein, G R ; Ciorba, M A ; Rogler, G...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S048-S049 , 2018
Link: https://doi.org/10.1093/..
 
?
10

Long‐term safety and efficacy of certolizumab pegol in the ..:

Sandborn, W. J. ; Lee, S. D. ; Randall, C....
Alimentary Pharmacology & Therapeutics.  40 (2014)  8 - p. 903-916 , 2014
Link: https://doi.org/10.1111/..
 
?
11

Mesalazine granules 1.5 g once‐daily maintain remission in ..:

Lichtenstein, G. R. ; Zakko, S. ; Gordon, G. L....
Alimentary Pharmacology & Therapeutics.  36 (2012)  2 - p. 126-134 , 2012
Link: https://doi.org/10.1111/..
 
?
12

Endoscopic mucosal healing in ulcerative colitis: authors' ..:

Lichtenstein, G. R. ; Ramsey, D. ; Rubin, D. T.
Alimentary Pharmacology & Therapeutics.  33 (2011)  11 - p. 1255-1256 , 2011
Link: https://doi.org/10.1111/..
 
?
13

Review article: delivery and efficacy of topical 5-aminosal..:

Harris, M. S. ; Lichtenstein, G. R.
Alimentary Pharmacology & Therapeutics.  33 (2011)  9 - p. 996-1009 , 2011
Link: https://doi.org/10.1111/..
 
?
14

Early symptomatic response and mucosal healing with mesalaz..:

Sandborn, W. J. ; Hanauer, S. ; Lichtenstein, G. R....
Alimentary Pharmacology & Therapeutics.  34 (2011)  7 - p. 747-756 , 2011
Link: https://doi.org/10.1111/..
 
?
15

Randomised clinical trial: delayed-release oral mesalazine ..:

Lichtenstein, G. R. ; Ramsey, D. ; Rubin, D. T.
Alimentary Pharmacology & Therapeutics.  33 (2011)  6 - p. 672-678 , 2011
Link: https://doi.org/10.1111/..
 
1-15